Overview

The Effects AZD8529 on Ketamine-induced Impairment of Working Memory in Healthy Volunteers

Status:
Completed
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess if ketamine will induce, in healthy volunteers, impairment of working memory and if the drug AZD8529 will block the effects of ketamine on working memory as assessed by functional magnetic resonance imaging (fMRI).
Phase:
Early Phase 1
Details
Lead Sponsor:
AstraZeneca
Treatments:
Ketamine